We are live on ! Find out more
SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

189 hedge funds and large institutions have $2.69B invested in Sage Therapeutics in 2017 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 71 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 15

43% more capital invested

Capital invested by funds: $1.88B → $2.69B (+$815M)

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

15% more funds holding

Funds holding: 165189 (+24)

2.79% more ownership

Funds ownership: 98.83%101.61% (+2.8%)

28% less repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 71

63% less call options, than puts

Call options by funds: $53.6M | Put options by funds: $145M

Holders
189
Holders Change
+24
Holders Change %
+14.55%
% of All Funds
4.71%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
46
Increased
51
Reduced
71
Closed
15
Calls
$53.6M
Puts
$145M
Net Calls
-$91M
Net Calls Change
-$88.7M
Name Holding Trade Value Shares
Change
Change in
Stake
BBHC
201
Brown Brothers Harriman & Co
New York
-$5K -92 Closed
Northwestern Mutual Wealth Management
202
Northwestern Mutual Wealth Management
Wisconsin
-$1K -28 Closed
Carson Wealth (CWM LLC)
203
Carson Wealth (CWM LLC)
Nebraska
+$351 +6 New